A multicenter, double blind, randomized, placebo controlled study to assess the safety and efficacy of bazedoxifene in postmenopausal Asian women.

Trial Profile

A multicenter, double blind, randomized, placebo controlled study to assess the safety and efficacy of bazedoxifene in postmenopausal Asian women.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Bazedoxifene (Primary)
  • Indications Bone resorption; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 07 Dec 2008 Results were reported at the 2008 IOF World Congress on Osteoporosis.
    • 14 Dec 2007 Status changed from in progress to completed according to Wyeth media release.
    • 16 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top